retatrutide trial results Breaking: New data just released. TRIUMPH-1 study on the triple agonist. Eli Lilly's clinical trial on Retatrutide (triple agonist compound). 80 weeks. Phase 3 data. The results: At 12mg Retatrutide: What It Is &

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial

You typically get it either as a standalone drug plan or as part of a Medicare Advantage plan that includes drug coverage

Disability-adjusted life years due to stroke have been constantly increasing since 1990 and were up 32.4% in 2019 (Roth et al., 2020)

The debate was reignited in 2025 when several large-scale analyses re-examined the association between GLP-1 therapy and pancreatic inflammation

And as you brought up diabetes, nobody ever debates if your pancreas stops working due to an autoimmune condition, should you or should you not take insulin

doi: 10.1186/1744-8069-8-16 66 KimN